Halberd Corp (HALB)

[EHRjunkie]

Research Partnership with ASU

On August 31, 2020 Halberd announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd’s Covid-19 treatments. The work will focus on developing antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of the virus’ antigens from a patient’s blood. It will also focus on neutralizing the effects of antigens and development of a potential therapeutic medication.

UTEP is out and ASU in in!!!